openPR Logo
Press release

Analgesics Market: Projected Compound Growth Rate 6.6% and Future Outlook 2030

07-26-2023 12:28 PM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Analgesics Market: Projected Compound Growth Rate 6.6%

The global analgesics industry was estimated at $26.7 billion in 2020, and is anticipated to hit $50.7 billion by 2030, registering a CAGR of 6.6% from 2021 to 2030.

Download Sample PDF at: https://www.alliedmarketresearch.com/request-sample/1254

Growing Demand: The analgesics market has experienced significant growth in recent years. The demand for pain relief medications has been driven by factors such as an aging population, increasing prevalence of chronic pain conditions, and rising awareness about pain management.

Over-the-Counter (OTC) Dominance: Over-the-counter analgesics, which are available without a prescription, dominate the market. Common OTC analgesics include nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and aspirin, as well as acetaminophen (paracetamol).

Prescription Analgesics: While OTC analgesics make up a large portion of the market, there is also a significant market for prescription-based pain medications. These include opioids, such as oxycodone and morphine, which are used for moderate to severe pain management.

Opioid Crisis Impact: The opioid crisis, characterized by widespread misuse and addiction to prescription opioids, has had a significant impact on the analgesics market. This has led to increased scrutiny and regulation of opioid prescriptions, as well as a push for alternative pain management strategies.

Market Drivers:

Increasing Prevalence of Chronic Pain: Chronic pain conditions, such as arthritis, lower back pain, and neuropathic pain, are widespread and contribute to the demand for analgesics. As the global population ages and the incidence of chronic pain conditions rises, the need for effective pain management medications increases.

Growing Global Population: The world's population is continuously increasing, which leads to a larger patient pool requiring pain relief medications. A larger population base, particularly among the elderly, drives the demand for analgesics.

Request for Customization - https://www.alliedmarketresearch.com/request-for-customization/1254

Market Segmentation:

Product Type:

a. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): This segment includes medications like ibuprofen, aspirin, and naproxen, which reduce pain and inflammation.
b. Acetaminophen (Paracetamol): Acetaminophen is a commonly used analgesic for relieving pain and reducing fever.
c. Opioids: This segment comprises potent pain relievers, including drugs like oxycodone, morphine, and codeine, typically used for moderate to severe pain.

Prescription-based vs. Over-the-Counter (OTC):
a. Prescription Analgesics: These are medications that require a prescription from a healthcare professional, typically used for more severe or chronic pain conditions.
b. Over-the-Counter (OTC) Analgesics: These are medications available without a prescription, commonly used for mild to moderate pain relief.

Route of Administration:

a. Oral Analgesics: Medications that are taken orally, such as tablets, capsules, or liquid formulations.
b. Topical Analgesics: Analgesics in the form of creams, gels, patches, or sprays that are applied directly to the skin for localized pain relief.
c. Parenteral Analgesics: Medications administered through injections or intravenous infusion, often used in hospital settings for acute or severe pain management.

Distribution Channel:

a. Retail Pharmacies: Analgesics available for purchase through traditional retail pharmacy outlets.
b. Online Pharmacies: Increasingly popular channels for purchasing analgesics, providing convenience and accessibility for consumers.
c. Hospital Pharmacies: Analgesics supplied and administered within hospital settings.

Procure Complete Report (258 Pages): https://www.alliedmarketresearch.com/purchase-enquiry/1254

Competitive Landscape:

Johnson & Johnson
Pfizer Inc.
GlaxoSmithKline plc
Novartis International AG
Bayer AG
Sanofi S.A.
Reckitt Benckiser Group plc
Teva Pharmaceutical Industries Ltd.
Endo International plc
Eli Lilly and Company

Related Reports :

Penicillin Drug Market https://www.alliedmarketresearch.com/penicillin-drug-market-A110795

Metastatic Cancer Drugs Market https://www.alliedmarketresearch.com/metastatic-cancer-drugs-market-A109351

Diabetic Foot Ulcer Treatment Market https://www.alliedmarketresearch.com/diabetic-foot-ulcer-treatment-market-A110954

Orthopedic 3D Printing Devices Market https://www.alliedmarketresearch.com/orthopedic-3d-printing-devices-market-A111259

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Allied Market Research Blog: https://blog.alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Analgesics Market: Projected Compound Growth Rate 6.6% and Future Outlook 2030 here

News-ID: 3146374 • Views: …

More Releases from Allied Market Research

Liability Insurance Market Global Opportunity Analysis and Industry Forecast, 20 …
Allied Market Research published a report, titled, "Liability Insurance Market by Coverage Type (General Liability Insurance, Professional Liability Insurance, Insurance for Directors and Officers), by Enterprise Size (Medium-sized Enterprises, Large Enterprises, Small Enterprises), by Application (Commercial, Personal): Global Opportunity Analysis and Industry Forecast, 2021-2031." According to the report, the global liability insurance industry generated $252.34 billion in 2021, and is expected to reach $432.81 billion by 2031, witnessing a CAGR…
Umbrella Insurance Market to Hit $170.7 Billion by 2031, Growing at 9.2% CAGR
Umbrella insurance is a form of casualty insurance designed to shield individuals from significant liability claims that surpass the coverage limits of their primary commercial general liability, business auto, and other business insurance policies. It offers a cost-effective solution for significantly increasing liability limits, providing added protection against catastrophic claims in today's unpredictable environment. Request Sample Pages Now: https://www.alliedmarketresearch.com/request-sample/15130 Allied Market Research published a report, titled, "Umbrella Insurance Market Size by Coverage…
Bancassurance Market to Reach $1.8 Trillion by 2031, Growing at 7.4% CAGR
Allied Market Research published a report, titled, "Bancassurance Market by Insurance Type (Life Insurance, Non-Life Insurance), by Model Type (Pure Distributor Model, Strategic Alliance Model, Joint Venture Model, Financial Holding, Others), by End User (Personal, Business): Global Opportunity Analysis and Industry Forecast, 2021-2031" According to the report, the global bancassurance industry generated $901.5 billion in 2021, and is estimated to reach $1.8 trillion by 2031, witnessing a CAGR of 7.4%…
Lendtech Market to Reach $61.9 Billion by 2031, Growing at 23.2% CAGR
Allied Market Research published a report, titled, "LendTech Market by Component (Solution and Services), Deployment Mode (On-Premises and Cloud), Type (Consumer Lending and Business Lending), Organization Size (Large Enterprises and Small and Medium-sized Enterprises), and End User (Banks, Insurance Companies, Credit Unions and NBFCs) And Region (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2022-2031" According to the report, the global lendtech industry generated $8 billion…

All 5 Releases


More Releases for Analgesics

Key Influencer in the Analgesics Market 2025: Elevated Prevalence Of Chronic Dis …
"How Are the key drivers contributing to the expansion of the analgesics market? The growing frequency of chronic health conditions fuels the expansion of the analgesics market. Analgesics, colloquially known as painkillers, are employed in combating extreme or long-lasting pain resulting from a variety of health disorders. For instance, a report from the World Health Organization (WHO) in September 2022 pointed out that chronic diseases, also dubbed noncommunicable diseases (NCDs), materialize…
Market Growth Opportunity in Analgesics
Global Analgesics Market: Overview Analgesics, or painkillers, are used to reduce and treat aches and pains. Internal and external analgesics are used to combat pain resulting from inflammation, cancer treatments, physiological injury, neuropathic conditions, surgeries, wounds, and phantom aches. The most prominent therapeutic classes of analgesics are local anesthesia, nonsteroidal anti-inflammatory drugs (NSAIDs), and opioids. The growing incidence of cancer worldwide and the rise in chronic diseases are mainly responsible for…
Global Antipyretic Analgesics Market Demand 2020-2025
This report also researches and evaluates the impact of Covid-19 outbreak on the Antipyretic Analgesics industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Antipyretic Analgesics and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.). GLOBAL INFO RESEARCH has recently published a research report titled, [Global Antipyretic Analgesics Market 2020 by Company, Regions, Type and Application, Forecast to…
Narcotic Analgesics: Future of Chronic Pain Management
The development of tolerance for non-narcotic analgesics is the primarily reason behind the constantly increasing sales for narcotic analgesics. Attributing to the higher efficacy in pain management and quick onset of action, narcotic analgesics are largely used in palliative care services for treating patients suffering from neuropathic pain. Increasing focus on palliative care services in third world countries and readily available reimbursements are the key factors expected to boost the…
Analgesics Market - Global Industry Analysis 2024
Analgesics, or painkillers, are used to reduce and treat aches and pains. Internal and external analgesics are used to combat pain resulting from inflammation, cancer treatments, physiological injury, neuropathic conditions, surgeries, wounds, and phantom aches. The most prominent therapeutic classes of analgesics are local anesthesia, nonsteroidal anti-inflammatory drugs (NSAIDs), and opioids. The growing incidence of cancer worldwide and the rise in chronic diseases are mainly responsible for the consistent growth…
Global Antipyretic Analgesics Sales Market Report 2017
This report studies sales (consumption) of Antipyretic Analgesics in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Crown Pharmaceuticals Medipaams India SRS Pharmaceuticals Umang Pharma YaoPharma ... Market Segment by…